Voyager Therapeutics Inc (VYGR)
7.42
-0.15
(-1.98%)
USD |
NASDAQ |
Apr 25, 16:00
7.41
-0.01
(-0.13%)
After-Hours: 20:00
Voyager Therapeutics Market Cap: 402.91M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 402.91M |
| April 24, 2024 | 411.06M |
| April 23, 2024 | 415.40M |
| April 22, 2024 | 411.06M |
| April 19, 2024 | 407.25M |
| April 18, 2024 | 409.97M |
| April 17, 2024 | 420.29M |
| April 16, 2024 | 433.32M |
| April 15, 2024 | 447.44M |
| April 12, 2024 | 457.75M |
| April 11, 2024 | 476.76M |
| April 10, 2024 | 479.47M |
| April 09, 2024 | 493.59M |
| April 08, 2024 | 491.96M |
| April 05, 2024 | 506.62M |
| April 04, 2024 | 495.76M |
| April 03, 2024 | 507.71M |
| April 02, 2024 | 538.12M |
| April 01, 2024 | 572.33M |
| March 28, 2024 | 505.54M |
| March 27, 2024 | 519.11M |
| March 26, 2024 | 544.09M |
| March 25, 2024 | 502.82M |
| March 22, 2024 | 489.25M |
| March 21, 2024 | 510.43M |
| Date | Value |
|---|---|
| March 20, 2024 | 562.01M |
| March 19, 2024 | 546.26M |
| March 18, 2024 | 493.59M |
| March 15, 2024 | 503.91M |
| March 14, 2024 | 495.76M |
| March 13, 2024 | 496.31M |
| March 12, 2024 | 493.59M |
| March 11, 2024 | 491.96M |
| March 08, 2024 | 508.80M |
| March 07, 2024 | 512.60M |
| March 06, 2024 | 501.19M |
| March 05, 2024 | 494.14M |
| March 04, 2024 | 523.46M |
| March 01, 2024 | 512.60M |
| February 29, 2024 | 451.78M |
| February 28, 2024 | 487.08M |
| February 27, 2024 | 483.82M |
| February 26, 2024 | 469.16M |
| February 23, 2024 | 444.18M |
| February 22, 2024 | 418.66M |
| February 21, 2024 | 414.86M |
| February 20, 2024 | 420.82M |
| February 16, 2024 | 419.71M |
| February 15, 2024 | 427.50M |
| February 14, 2024 | 409.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
93.32M
Minimum
Oct 05 2021
1.038B
Maximum
Jul 03 2019
362.24M
Average
334.66M
Median
Mar 20 2023
Market Cap Benchmarks
| Biogen Inc | 29.48B |
| United Therapeutics Corp | 11.11B |
| MEI Pharma Inc | 20.66M |
| Macrogenics Inc | 897.15M |
| Moderna Inc | 40.65B |
Market Cap Related Metrics
| PE Ratio | 2.446 |
| PS Ratio | 1.334 |
| Price to Book Value | 1.703 |
| Price to Free Cash Flow | 4.466 |
| Price | 7.42 |
| Earnings Yield | 40.89% |
| Operating PE Ratio | 2.733 |
| Normalized PE Ratio | 2.446 |